PLK1 and glioblastoma: The Cas9-mediated knockout of the Plk1 gene in the tumor in an orthotopic GBM mouse model effectively suppressed tumor growth, significantly improved the median survival time of mice from 18 days (PBS-treated) to 40 days, and meanwhile had negligible side effects.